RENT a BENCH Biotech Incubators Such As Labcentral Are Lowering Barriers to Entrepreneurship by Trisha Gura, in Cambridge, Massachusetts

Total Page:16

File Type:pdf, Size:1020Kb

RENT a BENCH Biotech Incubators Such As Labcentral Are Lowering Barriers to Entrepreneurship by Trisha Gura, in Cambridge, Massachusetts NEWS | FEATURES | ENTREPRENEURSHIP GOT A STARTUP? RENT A BENCH Biotech incubators such as LabCentral are lowering barriers to entrepreneurship By Trisha Gura, in Cambridge, Massachusetts ith its cookie-cutter windows and square-meter facility, now owned by the boxy brick exterior, the build- Massachusetts Institute of Technology ing here on Main Street could be (MIT) and leased to LabCentral, functions just another former 19th century as a life science “incubator” that helps bud- W warehouse or factory. It’s no sur- ding biotech firms combat the soaring costs prise to learn that passenger rail- of lab space and equipment in the red-hot road cars were once built in its spacious Boston-Cambridge region. Any scientist on June 11, 2015 interior. Yet the Cambridge landmark has with an idea and ambition can rent a bench a history not just of production, but also and an office, sharing space, services, and of innovation. In 1876, it housed the office high-cost tools with others pursuing their of Thomas Watson, assistant to Alexander own entrepreneurial dreams. “It is very ex- Graham Bell, when the pair made the first citing because we are there at the nascent two-way long-distance phone call, to Bos- moment of many really, really cool com- ton. In the 20th century, it was home to Po- panies,” says molecular biologist Johannes laroid and the lab of Edwin Land when he Fruehauf, a LabCentral founder. invented the instant camera. It’s also the nascent moment for facili- www.sciencemag.org Today, a nonprofit organization called ties like LabCentral. Similar incubators are LabCentral has taken up that entrepre- opening up in Cambridge, San Francisco, neurial heritage. The renovated, 2600- and other hotbeds of life science entre- preneurship, and startup companies are lining up to rent space. Incubators lower the entry barrier to the entrepreneur- ial world, foster networking, and serve as showcases of gleaming ideas for ven- in the so-called Boston Innovation Super- Downloaded from ture capitalists and bigger companies to cluster that encompasses MIT and a slew of browse. As startup founder Laura Hales, life science companies. whose company Extend Biosciences was He successfully negotiated the lease, ren- one of LabCentral’s first tenants, puts it: ovated and equipped the lab, and jumped “If you start talking to big pharma, you through the daunting hurdles of permitting need to show them that you are estab- and compliance. But Fruehauf also burned lished. Anyone who walks into this place through $1.5 million and 6 months before is immediately impressed. It just speaks he or colleagues could even lift a pipette. for itself.” “In retrospect, it was really a bad use of our capital and time,” he says. THE IDEA BEHIND LABCENTRAL dawned Fast-forward a year. Li had sold Cequent in 2009 when Fruehauf’s Ph.D. adviser, to another company for $46 million, and gastroenterologist Chiang Li at Beth Israel Fruehauf was launching his own enterprise, Deaconess Medical Center, launched Ce- called ViThera, based on a probiotic tech- quent Pharmaceuticals, bent on delivering nology licensed from a French group. Bank- molecular payloads of artificial RNA via rolled only by his own money—he wanted 2 genetically engineered bacteria. Backed by to stay away from venture capital funding— S I V $22 million in venture capital and with Fruehauf had to find a cheaper way. A UL A P Molecular biologist Johannes Fruehauf and investor a staff that quickly swelled to 17 people, So, he subleased lab space from a Kend- S: O Peter Parker, two of LabCentral’s founders, with Olivier Fruehauf chose a space at One Kendall all Square–based company called Pervasis, T O H Boss, a tenant at an earlier incubator (left to right). Square, a hub of contemporary buildings which was downsizing. Then he brought P 1196 12 JUNE 2015 • VOL 348 ISSUE 6240 sciencemag.org SCIENCE Published by AAAS in cash by essentially subletting the sub- cessful; it gleaned a $90,000 Small Busi- Shannon Pendergrast and Anna Markowska let. Word got out, demand increased, ness Technology Transfer (STTR) grant that of biotech startup Ymir value the networking and by January 2011, Fruehauf spun off a Boss and Farmer shared. However, Boss opportunities at LabCentral. new company—eventually called Cam- still needed to conduct a commercial pi- bridge Biolabs (CBL)—designed to provide lot study. In figuring out where to do that, grant. He transplanted his brown fat cells tailor-made, minimal units of lab space for he found himself in a tricky situation, one into mice, and 3 years later—still rent- early startup companies. encountered by many a potential scientific ing from Fruehauf at CBL—has won an- Olivier Boss was one of his first custom- entrepreneur. “People get in trouble when other $1 million in grant money and ers. Coming out of a small biotech company they start companies around academic partnered with pharmaceutical giant focused on thwarting obesity, Boss and two technology and continue to use academic Johnson & Johnson on a project that may colleagues launched Energesis Pharma- resources,” Fruehauf says. Many, he adds, lead to clinical trials of brown fat therapies ceuticals to develop a technology based end up “fudging things” or conducting in people. on brown fat, which generates body heat “submarine projects” that proceed under- Could he have done it without the incu- by metabolizing stored fat. Desperately neath the university radar. bator? “Absolutely not,” Boss says. “That lab needing access to a lab, Boss initially col- Boss wanted to do it right. He unearthed space was what we needed. And not just us.” laborated with Stephen Farmer, an obesity “the best option, the only option,” he says, researcher at the Boston University School when he met Fruehauf in 2010. Then trying THE SUCCESS OF CBL prompted Fruehauf to of Medicine, but could only work in the to bootstrap ViThera, Fruehauf offered Boss gather backers, most notably $5 million from laboratories there for academic goals, a bench and use of the company’s lab facili- a Massachusetts state life science initiative, to i.e., to churn out brown fat stem cells for ties for $3000 a month. Boss accepted and found a second incubator, LabCentral, in the Farmer’s studies. in 6 months obtained results that convinced back half of the Main Street landmark. The By one standard, the strategy was suc- enough people to score a $750,000 STTR space is a scientific entrepreneur’s dream, SCIENCE sciencemag.org 12 JUNE 2015 • VOL 348 ISSUE 6240 1197 Published by AAAS NEWS | FEATURES | ENTREPRENEURSHIP replete with cell culture facilities, biosafety ure if they offer their services—such as ad- are increasingly backing and partnering level 2 labs, and a dizzying array of gadgets vice on patent filings—cheaply and early on, with startups, particularly at incubators. for analyzing cells, DNA, and proteins. A new the relationship will blossom as early-stage They are realizing that “a few hundred glass-enclosed entrance has a patio for net- companies grow up and move out. thousand dollars invested in a three-person working and the interior includes immacu- Besides, what fledgling entrepreneur has company gives huge amount of return on late common spaces—lounges with video the time and money to slog through envi- investment,” Crawford says. games, glass-walled conference rooms, and ronmental health and safety compliance? For big companies searching for new a well-stocked kitchen with an “As a scientist entrepreneur, ideas, incubators are a convenient place espresso machine. The place your time should be exclu- to look. By attending talks, symposia, and buzzes 24/7—different startup sively focused on what other events at the incubators, the big companies even share work- “We are there problem your business can fish can land the most attractive startups, benches in shifts through- at the nascent solve and how are you using whether by investing in their technology, out the day and night to science to address that,” funding specific projects, or buying the save money. moment of many says John McQuillan, CEO companies outright. In fact, Pfizer leases The arrangement is analo- really, really and president of Triumvi- part of the Main Street building and spon- gous to cloud computing in rate Environmental, a Lab= sors LabCentral for an undisclosed sum—in the information technology cool companies.” Central founding sponsor exchange for picking the recipients of two world, which gives high-tech Johannes Fruehauf, that provides advice and LabCentral slots. entrepreneurs a cheap alter- LabCentral waste management/environ- LabCentral tenants also help each other. native to purchasing costly mental services to life science Hales and her partner at Extend, virolo- computer hardware. LabCentral and other companies. “Any other question ought to be gist Tarik Soliman, for example, partnered incubators essentially proffer a cloud for handed over to somebody else.” up with researchers on the same floor at a life science research. “We dedicated our- company called Advirna. The two startups selves to breaking down the expensive lab STARTUPS LIKE the approach. LabCentral co-wrote a Small Business Innovation Re- resource into such small increments that reached capacity within 6 months of open- search grant proposal to tack the vitamin D any entrepreneurial scientist with a credit ing in 2014—and now has a long waiting metabolites developed by Extend onto card can get going,” says Douglas Crawford, list. Similarly, within a half-year of opening Advirna’s RNAs and so prevent their degra- associate director of QB3, a University of in 2013, QB3 filled one 2230-square-meter dation in the body. The project was funded California (UC) research institute that pro- incubator with 46 startup companies, most by the National Institutes of Health.
Recommended publications
  • Annual Report
    Fiscal Year 2015 Annual Report To: Governor Charlie Baker Secretary of Administration and Finance Kristen Lepore Secretary of Housing & Economic Development Jay Ash Senate President Stan Rosenberg Speaker of the House Robert DeLeo State Comptroller Thomas G. Shack III Clerk of the Senate William Welch Clerk of the House of Representatives Steven James By forward: House and Senate Committees on Ways and Means and the Joint Committee on Economic Development and Emerging Technologies Date: September 30, 2015 Re: FY 2015 Annual Report of the Massachusetts Life Sciences Center The Massachusetts Life Sciences Center (MLSC) respectfully submits this Annual Report detailing the organization’s operations and accomplishments during Fiscal Year (FY) 2015. For the past seven years, the MLSC has led the state’s life sciences initiative – a $1 billion initiative designed to strengthen the state’s economy by accelerating the growth of our life sciences sectors in Massachusetts. The MLSC’s goal has been to make Massachusetts the strongest life sciences ecosystem in the world and the best place in the world for life sciences companies to do business. The MLSC collaborates with the private sector to accelerate the pace of innovation and economic development in all regions of Massachusetts. The MLSC’s strategy has been based on the belief that the best role for the state is to invest in Massachusetts’ innovation capacity – the ability to produce and commercialize a flow of innovative life sciences technologies over the long term. Since 2008, the MLSC has invested aggressively in five “enablers” that build innovation capacity: translational research, entrepreneurship, workforce development, infrastructure and collaboration.
    [Show full text]
  • View Annual Report
    GENOCEA BIOSCIENCES, INC. FORM 10-K (Annual Report) Filed 02/27/15 for the Period Ending 12/31/14 Address 100 ACORN PARK DRIVE CAMBRIDGE, MA 02140 Telephone 617-876-8191 CIK 0001457612 Symbol GNCA SIC Code 2836 - Biological Products, Except Diagnostic Substances Fiscal Year 12/31 http://www.edgar-online.com © Copyright 2015, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36289 Genocea Biosciences, Inc. (Exact name of registrant as specified in its charter) Delaware 51 -0596811 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 100 Acorn Park Drive Cambridge, Massachusetts 02140 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (617) 876-8191 Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which Title of each class registered Common Stock, $0.001 par value NASDAQ Global Market Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
    [Show full text]
  • Annual Report
    HUMAN CAPITAL FISCAL YEAR 2019 ANNUAL REPORT INNOVATION CAPITAL GROWTH CAPITAL INTELLECTUAL CAPITAL The capital of scientific revolution. Fiscal Year 2019 Annual Report • Massachusetts Life Sciences Center • i BOARD OF DIRECTORS TABLE OF CONTENTS A LETTER FROM THE INTERIM PRESIDENT & CEO Michael J. Heffernan Co-Chair; Secretary, Executive Office for Administration & Finance A Letter from the President & CEO ...........................................................................................1 Mike Kennealy Co-Chair; Secretary, Executive Office Vision & Strategy: The Capital of Scientific Revolution ......................................................2 The Patients Are Waiting of Housing & Economic Development Fiscal Year 2019 Highlights and The Bottom Line ..............................................................3 Gary P. Kearney, MD Around the globe, billions of patients and their loved ones await advances in health President, Longwood Urological Associates Human Capital care that will produce the products, devices, and therapies to alleviate suffering, Marty Meehan Internship Challenge: Enhancing Career Exploration improve treatment, and save lives. Much of that attention falls on Massachusetts, as President, University of Massachusetts and Expanding the Talent Pipeline ............................................................................................4 the world looks to our ecosystem to deliver the breakthroughs that further unlock our Peter Parker understanding of human physiology, harness the power of data science,
    [Show full text]
  • Science-USA (Boston+), November 2012
    Schweizerische Eidgenossenschaft Confédération suisse Confederazione Svizzera Confederaziun svizra Science-USA (Boston+), November 2012 Table of Contents 1. Policy ........................................................................................................................................................................................ 1 2. Education .................................................................................................................................................................................. 2 3. Life Science .............................................................................................................................................................................. 3 4. Nano / Micro Technology / Material Science ............................................................................................................................. 4 5. Information & Communications Technology ............................................................................................................................. 6 6. Energy / Environment ............................................................................................................................................................... 6 7. Engineering / Robotics / Space ................................................................................................................................................. 8 8. Physics / Chemistry / Math ......................................................................................................................................................
    [Show full text]
  • GUIDE to Doing Business on the US East Coast for Dutch Companies Information for Small and Medium Enterprises, Startups, and Scale-Ups 2 Contents
    LOPENDE TITEL 1 GUIDE TO Doing Business on the US East Coast for Dutch Companies Information for small and medium enterprises, startups, and scale-ups 2 Contents Introduction 5 Foreword Ambassador Haspels 6 Foreword Pauline Dirkmaat 7 Chapter 1: An introduction to the US East Coast 8 1 The US East Coast: a Great Place for Internationalizing Companies 9 2 East Coast vs. West Coast 10 3 Business Culture 11 4 Dutch Government Network on the East Coast 12 Chapter 2: Practical Information for Setting Up a Business on the US East Coast 13 1 Legal Aspects 14 1.1 The three Levels of Law & Incorporation 14 1.2 Immigration: Getting to and Staying in the US 14 1.3 Insurance 15 2 Finance and Banking 15 3 Human Resources 15 4 Communication and Networking 16 4.1 Communication Tips 16 4.2 Networking Tips 17 5 Practical Tips for Startups 18 5.1 Raising Capital 18 5.2 Pitching 19 5.3 Other Resources for Startups 20 Chapter 3: Boston 21 1 Introduction 22 2 Why Boston? 23 3 Key Sectors in Boston 23 3.1 Life Sciences and Health 23 3.2 Cleantech 24 3.3 Artificial Intelligence 24 3.4 Robotics 25 3.5 Edtech, FinTech and Cybersecurity 25 4 Startup Ecosystem Drivers 26 5 Other Resources 28 Chapter 4: New York City 30 1 A Brief Background 31 2 Why New York City? 31 3 Key Sectors & Opportunities 32 3.1 Finance, FinTech & Cybersecurity 32 3.2 Life Sciences and Health and Biotech 32 3.3 Creative Industries 33 3.4 Manufacturing 34 3.5 Circular Economy & Resiliency 34 3.6 Cleantech & Energy 35 3.7 Water Management & Resiliency 35 4 Startups and Scale-ups 35 5 New York Online Resources 38 CONTENTS 3 Chapter 5: Washington, D.C.
    [Show full text]
  • LIVIO VALENTI CV 2011-Present VAXESS TECHNOLOGIES, INC
    LIVIO VALENTI CV Livio Valenti is the co-founder of Vaxess Technologies and Giorgio Ruffolo Research Fellow in the Sustainability Science Program at Harvard Kennedy School of Government and the Harvard Global Health Institute. He received a Master in Public Policy from Harvard’s Kennedy School of Government in 2013, where he was the recipient of the Empedocle Maffia Fellowship provided by the Italian Government to one outstanding individual to attend Harvard. While a student at Harvard, he co-founded Vaxess Technologies, an innovative life sciences company that aims to create vaccines that do not need refrigeration. Vaxess has raised $4.75m in venture capital, angel investors, and various public institutions, including the Massachusetts Life Science Center (MLSC). Harvard Business School (HBS) published a case on Vaxess in 2014. Livio was named by Forbes one of the 30 under 30 individuals likely to change the world for his commitment in improving global health and one of the 10 under 40 (PrimiDieci-Under40 2014) most distinguished individuals with Italian origins or Italian nationality currently in the USA by the Italian-American Chamber of Commerce and the Italian Ministry of Foreign Affairs. His academic research at Harvard focuses on the space at the intersection between Government and Business. Livio is researching the potential to sustainably commercialize innovative technologies to improve global health. He is contributing to collaborative work with the Initiative on Innovation and Access to Technologies for Sustainable Development led by William Clark. Professional experience Prior to studying at Harvard, Livio worked for the United Nations in several developing countries. His work included advising government clients and international financing institutions in the identification, appraisal and financing of large investment projects.
    [Show full text]
  • Genocea Biosciences, Inc. (Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material under §240.14a-12 Genocea Biosciences, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): ☒ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the (3) filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: o Fee paid previously with preliminary materials. Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee o was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: 1 Genocea Biosciences, Inc.
    [Show full text]
  • [email protected] | 1.617.863.3650
    Frequently Asked Questions Media contact: Caroline A. Grossman 781.771.5579 [email protected] What is LabCentral? A 28,000 square-foot facility in the heart of the Kendall Square, Cambridge, biotech innovation hub, LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. It offers fully permitted laboratory and office space for as many as 25 startups comprising approximately 100 scientists and entrepreneurs. LabCentral provides first-class facility and administrative support, skilled laboratory personnel, a domain-relevant expert speaker series ‒ as well as the other critical services and support that early-stage companies need to begin laboratory operations on day one. A private, nonprofit institution, LabCentral was funded in part by a $5 million grant from the Massachusetts Life Sciences Center (MLSC), with support from its real-estate partner, MIT. Founding sponsors include Triumvirate Environmental and Johnson & Johnson Innovation. The first startups began move-in early November, with lab operations launching officially November 15, 2013. When was LabCentral founded? LabCentral was incorporated in September 2012, and opened its doors on November 1, 2013. What is its current staffing? LabCentral staff includes: Johannes Fruehauf president, co-founder Ian Williams facilities manager Peter Parker director of programming, co-founder Thierry Leclerc lab service specialist Margaret O’Toole vice president, operations Patrick Tucker IT associate Celina Chang associate director, lab operations Clancy Steele office assistant Krista Licata office manager Amanda Duong office assistant Founding sponsor, Triumvirate Environmental, provides environmental health and safety services. How many lab bench and office spaces are available? There is a monthly per-person membership fee of $400.
    [Show full text]
  • Class of 2013 Employment Overview 76
    HARVARD KENNEDY SCHOOL 617-495-1161 [email protected] www.hks.harvard.edu/career CAREER ADVANCEMENT t t t EMPLOYMENT OVERVIEW Class of 2013 HARVARD KENNEDY SCHOOL t CLASS OF 2013 EMPLOYMENT OVERVIEW This overview reflects the diverse employment choices of Harvard Kennedy School (hks) class of The following report on the class of 2013 May graduates immediately post-graduation. 2013 is based on data collected from The Kennedy School degrees continue to show May through October 2013. The hks resilience in an uncertain economy, with our Office of Career Advancement (oca) employed a variety of data collection graduates settling around the globe and across techniques including an exit survey sectors and industries. We invite you to read taken at graduation, a follow-up survey about how our graduates have chosen to serve in September, and individual email inquiries. Overall response rate was 91 the public good through their professional work. percent; of those, 90 percent reported employment or plans to continue in an educational program as of October. OVERVIEW OF GRADUATING 2013 CLASS from 76 539 students countries 242 international MPA/ID MPA2 62 82 12 43 Concurrent/ Concurrent/ Joint Degree Joint Degree MC/MPA MPP 202 193 32 Concurrent/ Joint Degree 87 Concurrent/Joint Degree Students MBA: 69 / Law: 11 / MD: 5 / Divinity: 1 / Design: 1 HARVARD KENNEDY SCHOOL 617-495-1161 [email protected] www.hks.harvard.edu/career CAREER ADVANCEMENT t t t EMPLOYMENT OVERVIEW Class of 2013 HIGHLIGHTS GRADUATES t Eight graduates were selected as t Nonprofit/ngo employment is down IN 2013 finalists in the U.S.
    [Show full text]
  • Annual Report Table of Contents
    2019 Annual Report Table of Contents LEADERSHIP MESSAGE ...............................1 WHAT WE DO ......................................2 PEER SERVICES ....................................4 EARLY INTERVENTION ...............................6 RESIDENTIAL SERVICES ..............................8 INDIVIDUAL SUPPORTS ..............................10 60 YEARS OF CENTER CLUB ...........................12 SPECIAL EVENTS ..................................14 BAY COVE SUPPORTERS .............................16 FINANCIAL REPORT ................................23 GET INVOLVED ...................................24 BOARD MEMBERS AND SENIOR LEADERSHIP ...............25 Special thanks to photographer Aynsley Floyd for the stunning feature portraits in this report. Additional photography by Sean Browne, David Hirschberg and Josh Wardrop. Design by Mirage Design. OUR MISSION Bay Cove Human Services partners with people to overcome challenges and realize personal potential. OUR COMMITMENT To carry out the Bay Cove mission by providing individualized and compassionate services to people with developmental disabilities, mental illness, substance use disorders, aging-related challenges and/or homelessness. Dear Friends, Since Bay Cove was founded in 1974, one of our core principles has been that there is no “one size fits all” approach to delivering services—to working with someone with a substance use disorder, psychiatric or developmental disability, or experiencing homelessness. Each person we serve is a unique individual, with their own set of skills and goals, and it is our job to help them pursue those goals. Bill Sprague When we talk, in our agency mission statement, about partnering with people to overcome President and CEO challenges, we mean a true partnership—one where Bay Cove staff members and the person being served work together to achieve a common objective. We know that our exceptional staff will be there to offer support every step of the way, but that it’s the determination and perseverance of each individual that leads to successes, large and small.
    [Show full text]
  • Fiscal Year 2015 Annual Report
    Fiscal Year 2015 Annual Report To: Governor Charlie Baker Secretary of Administration and Finance Kristen Lepore Secretary of Housing & Economic Development Jay Ash Senate President Stan Rosenberg Speaker of the House Robert DeLeo State Comptroller Thomas G. Shack III Clerk of the Senate William Welch Clerk of the House of Representatives Steven James By forward: House and Senate Committees on Ways and Means and the Joint Committee on Economic Development and Emerging Technologies Date: September 30, 2015 Re: FY 2015 Annual Report of the Massachusetts Life Sciences Center The Massachusetts Life Sciences Center (MLSC) respectfully submits this Annual Report detailing the organization’s operations and accomplishments during Fiscal Year (FY) 2015. For the past seven years, the MLSC has led the state’s life sciences initiative – a $1 billion initiative designed to strengthen the state’s economy by accelerating the growth of our life sciences sectors in Massachusetts. The MLSC’s goal has been to make Massachusetts the strongest life sciences ecosystem in the world and the best place in the world for life sciences companies to do business. The MLSC collaborates with the private sector to accelerate the pace of innovation and economic development in all regions of Massachusetts. The MLSC’s strategy has been based on the belief that the best role for the state is to invest in Massachusetts’ innovation capacity – the ability to produce and commercialize a flow of innovative life sciences technologies over the long term. Since 2008, the MLSC has invested aggressively in five “enablers” that build innovation capacity: translational research, entrepreneurship, workforce development, infrastructure and collaboration.
    [Show full text]
  • New Horizons in Science
    Council for the Advancement CASWof Science Writing Fifty-Third Annual Briefing New Horizons in Science HOSTED BY KNIGHT SCIENCE JOURNALISM MASSACHUSETTS INSTITUTE OF TECHNOLOGY PART OF CAMBRIDGE, MASSACHUSETTS OCTOBER 9–13, 2015 www.casw.org/new-horizons THANK YOU! CASW THANKS OUR HOSTS AND SPONSORS CONFERENCE HOST ksj.mit.edu PLATINUM SPONSOR www.jnjinnovation.com GOLD SPONSOR statnews.com SEE INSIDE BACK COVER FOR MORE SPONSORS #SCIWRI15 FRIDAY Hosted event, trip or tour OCTOBER 9 NASW workshop registration required 11 a.m. – 5 p.m. NASW Board Meeting noon – 5 p.m. Check-in Hyatt Regency Cambridge lobby 1 – 5 p.m. How to make awesome science video: A hands-on workshop Thomas Paine Room, Hyatt Regency Cambridge Nonfiction book proposals: A hands-on workshop Charles View Ballroom, Hyatt Regency Cambridge 6 – 9 p.m. Knight Science Journalism welcome reception MIT Walker Memorial, 142 Memorial Drive Buses depart from Hyatt Check-in MIT Walker Memorial 9 – 10:30 p.m. Diversity Mixer Paul Revere Room, Hyatt Regency Cambridge SATURDAY OCTOBER 10 7:30 a.m.–5:30 p.m. Check-in Hyatt Regency Cambridge lobby 7:30 a.m.–6 p.m. National Association of Science Writers meeting and workshops Hyatt Regency Cambridge 6:30 – 9 p.m. Awards reception President’s Ballroom, Hyatt Regency Cambridge 1 New Horizons in Science AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY SUNDAY OCTOBER 11 7 – 8:15 a.m. Continental breakfast Kresge Lobby 7:30 – 11 a.m. Check-in Kresge Lobby 8:15 – 9:30 a.m. Opening plenary Kresge Auditorium Welcome Maria Zuber vice president for research, MIT Lighting up biology: The quest to see every molecule in every cell It may seem that 21st-century biologists have a fantastic array of tools for probing the workings of molecules, cells, and organisms.
    [Show full text]